• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Buy" by Analysts

    Source: Buzz FX / 23 Dec 2024 03:06:12   America/New_York


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat December 23, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has earned an av
    Read more...
Share on,